"People were surprised [by the deal] because we had been making a lot of progress and moving quickly [on our own]," Wave Life Sciences Ltd. CEO Paul Bolno told BioWorld, talking about the arrangement disclosed this week with Takeda Pharmaceutical Co. Ltd., a pact "very much aligned with our strategy, which is growth to becoming a fully integrated company."